Urology - urothelial cancer, Malmö
1 – 10 of 165
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Breast cancer recurrence in relation to mode of detection : implications on personalized surveillance
(
- Contribution to journal › Article
-
Mark
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI) : a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
(
- Contribution to journal › Article
-
Mark
Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT : a comparison to MRI using histopathology as reference
(
- Contribution to journal › Article
-
Mark
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer : A Nationwide Population-based Study
(
- Contribution to journal › Article
-
Mark
The association between animal protein, plant protein, and their substitution with bladder cancer risk : a pooled analysis of 10 cohort studies
(
- Contribution to journal › Article
-
Mark
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer : A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
(
- Contribution to journal › Article
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
(
- Contribution to journal › Article
-
Mark
Risk of invasive penile cancer after treatment of penile intraepithelial neoplasia
(
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
2025) In European Urology Focus(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
(
- Contribution to journal › Article